Early diagnosis key in combating the deadly effects of AL amyloidosis

FHS
June 27, 2024
5:40 am

AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death.

Astellas agrees to take over Propella Therapeutics for $175m

Share this article Astellas plans to fund the acquisition of Propella using cash on hand. Credit: JHVEPhoto / Shutterstock.com. Astellas Pharma has signed an agreement for

November 16, 2023

Arrivo bags $45M Series B to fund major depression late-stage test and PhII-ready pancreatitis asset

Arrivo BioVentures has closed an oversubscribed $45.25 million Series B fundraise with an eye to progress its pipeline through the next stage of trials, including

November 30, 2023

Study shows positive impact of medical marijuana laws on mental health

The approval of marijuana for medical use has had little effect on the mental health of the general population in the US. But legalization for

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.